Literature DB >> 9063748

p53 activates Fanconi anemia group C gene expression.

W Liebetrau1, A Budde, A Savoia, F Grummt, H Hoehn.   

Abstract

The tumor suppressor protein p53 (wtp53) can bind to specific target sequences and activate transcription of genes adjacent to these DNA elements. Two p53 binding sites are present in the gene coding for the Fanconi anemia complementation group C (FAC), one in the promoter region (from -1295 to -1266) and one in the coding region of FAC (from +1828 to +1848). Gel shift experiments show that wtp53 binds to the p53 target sequence in the promoter region of the FAC gene. We have investigated whether binding of p53 to these target sites may affect expression of the FAC gene. Transfection experiments show that overexpression of wtp53 in human diploid fibroblasts and lymphoblasts augments transcription of the FAC gene up to three-fold. The transfection efficacy was approximately 15% for both cell types. The FAC expression activity per transformed cell was stimulated to an estimated level of 18- to 21-fold upon overexpression of p53. The tumor-derived p53 mutants, His175 and His273, that fail to bind DNA showed only a reduced stimulatory activity on FAC transcription. Luciferase assays demonstrated that interaction of p53 with its target site in the FAC promoter does not modulate the promoter activity. We suggest that the p53 binding site contributes to, but may not be an absolute prerequisite for p53-directed transcriptional activation. We conclude that the FAC gene can be added to the list of genes that interact with p53.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9063748     DOI: 10.1093/hmg/6.2.277

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  9 in total

1.  Fanconi anemia proteins and endogenous stresses.

Authors:  Qishen Pang; Paul R Andreassen
Journal:  Mutat Res       Date:  2009-07-31       Impact factor: 2.433

2.  Cloning of the bovine and rat Fanconi anemia group C cDNA.

Authors:  J Ching Ying Wong; N Alon; M Buchwald
Journal:  Mamm Genome       Date:  1997-07       Impact factor: 2.957

Review 3.  DNA damage responses and p53 in the aging process.

Authors:  Hui-Ling Ou; Björn Schumacher
Journal:  Blood       Date:  2017-11-15       Impact factor: 22.113

Review 4.  Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.

Authors:  T Yamashita; T Nakahata
Journal:  Int J Hematol       Date:  2001-07       Impact factor: 2.490

5.  Upregulation of Fanconi anemia DNA repair genes in melanoma compared with non-melanoma skin cancer.

Authors:  Wynn H Kao; Adam I Riker; Deepa S Kushwaha; Kimberly Ng; Steven A Enkemann; Richard Jove; Ralf Buettner; Pascal O Zinn; Néstor P Sánchez; Jaime L Villa; Alan D D'Andrea; Jorge L Sánchez; Richard D Kennedy; Clark C Chen; Jaime L Matta
Journal:  J Invest Dermatol       Date:  2011-06-23       Impact factor: 8.551

6.  The transcription factor p53: not a repressor, solely an activator.

Authors:  Martin Fischer; Lydia Steiner; Kurt Engeland
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

7.  Systems biology-based identification of crosstalk between E2F transcription factors and the Fanconi anemia pathway.

Authors:  Moe Tategu; Takako Arauchi; Rena Tanaka; Hiroki Nakagawa; Kenichi Yoshida
Journal:  Gene Regul Syst Bio       Date:  2007-05-01

Review 8.  The ubiquitin-proteasome system in cancer, a major player in DNA repair. Part 2: transcriptional regulation.

Authors:  Panagiotis J Vlachostergios; Anna Patrikidou; Danai D Daliani; Christos N Papandreou
Journal:  J Cell Mol Med       Date:  2009-06-11       Impact factor: 5.310

Review 9.  DNA repair and aging: the impact of the p53 family.

Authors:  Sara Nicolai; Antonello Rossi; Nicola Di Daniele; Gerry Melino; Margherita Annicchiarico-Petruzzelli; Giuseppe Raschellà
Journal:  Aging (Albany NY)       Date:  2015-12       Impact factor: 5.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.